## Fungal Corneal Ulcer — First-Line Antifungal Therapy **Key Point:** Natamycin 5% is the **gold-standard topical antifungal** for fungal keratitis, particularly for filamentous fungi (Aspergillus, Fusarium) and Candida species. ### Why Natamycin 5% Is First-Line 1. **Broad antifungal spectrum**: Effective against most clinically relevant fungi — Candida, Aspergillus, Fusarium, Cephalosporium. 2. **Excellent corneal penetration**: Polyene macrolide with superior corneal epithelial and stromal penetration compared to azoles. 3. **Fungistatic + fungicidal**: Binds to fungal cell membrane ergosterol, disrupting membrane integrity. 4. **Minimal systemic absorption**: Topical application achieves high local concentration with negligible systemic toxicity. 5. **Proven efficacy**: Multiple randomized trials (including the Mycotic Ulcer Treatment Trial — MUTT) demonstrate superior healing rates with natamycin vs. voriconazole for filamentous fungi. ### Dosing and Administration - **Frequency**: Every 1–2 hours while awake (initially), then taper as ulcer improves. - **Duration**: 4–6 weeks or until complete epithelialization and stromal clearing. - **Adjunct**: Systemic antifungal (oral itraconazole or voriconazole) for deep stromal or scleral involvement. **High-Yield:** Natamycin is **insoluble in water** — it is supplied as a **suspension**, not a solution. Shake the bottle before each use to ensure uniform concentration. ### Comparison of Topical Antifungal Agents | Agent | Class | Spectrum | Corneal Penetration | Indication | Advantage | Limitation | |-------|-------|----------|-------------------|-----------|-----------|------------| | Natamycin 5% | Polyene | Filamentous fungi, Candida | Excellent | **Empirical fungal ulcer** | Best overall efficacy | Suspension (shake before use); less effective for Candida alone | | Amphotericin B 0.15% | Polyene | Broad (fungi + some Candida) | Moderate–good | Candida, severe infections | Fungicidal | Corneal toxicity at higher concentrations; less available | | Voriconazole 1% | Azole | Filamentous fungi, Candida | Good | Candida-predominant, azole-resistant | Good for Candida | Inferior to natamycin for Aspergillus/Fusarium (MUTT trial); slower healing | | Fluconazole 0.2% | Azole | Candida > filamentous | Poor | Candida keratitis | Oral formulation available | Weak corneal penetration; not recommended for filamentous fungi | **Clinical Pearl:** The **feathery borders** and **branching septate hyphae** in this case are classic for **Aspergillus** (a filamentous fungus) — natamycin is the proven first-line choice. Aspergillus is the most common cause of fungal keratitis in tropical/subtropical regions (India, Africa) due to agricultural trauma. **Warning:** Do not use **systemic azoles alone** (fluconazole, itraconazole) as monotherapy for fungal keratitis — corneal penetration is insufficient. Always combine with topical natamycin or amphotericin B. **Mnemonic:** **NAFVAC** — **N**atamycin (first-line), **A**mphotericin B, **F**ilamentous fungi, **V**oriconazole, **A**zoles, **C**andida. - For filamentous fungi (Aspergillus, Fusarium) → **Natamycin** first. - For Candida alone → Natamycin or Amphotericin B. - Azoles (voriconazole, fluconazole) → second-line or adjunct only.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.